Financials
- Market Capitalization 751.02 M
- Employee 22
- Founded 2014
- CEO N/A
- Website www.monopartx.com
- Headquarter Delaware, United States
- FIGI BBG00J7K8D90
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2637 | NVCT Nuvectis Pharma, Inc. - Common Stock | 23.73 USD | -5.80% | +0.72% | +12.52% | +265.08% | 773.16 M USD | ||
| 2643 | AURA Aura Biosciences, Inc. - Common Stock | 7.40 USD | -3.90% | -5.13% | +5.56% | +18.40% | 767.42 M USD | ||
| 2667 | PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 9.18 USD | +2.68% | +3.38% | +3.15% | -23.37% | 742.67 M USD | ||
| 2674 | GYRE Gyre Therapeutics, Inc. - Common Stock | 6.59 USD | -1.35% | -4.35% | +15.21% | -20.22% | 734.85 M USD |
Frequently asked questions about Monopar Therapeutics Inc. Common Stock
What is the Monopar Therapeutics Inc. Common Stock stock price today?
The current price of Monopar Therapeutics Inc. Common Stock (MNPR) is 111.89. Over the past 24 hours, the stock has changed by -1.80%. Follow the MNPR chart for real-time price dynamics.
What is the stock ticker of Monopar Therapeutics Inc. Common Stock?
Monopar Therapeutics Inc. Common Stock trades under the ticker MNPR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Monopar Therapeutics Inc. Common Stock stock going up?
MNPR has changed by +4.60% over the last week, +3.63% over the last month, and +104.85% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Monopar Therapeutics Inc. Common Stock?
Monopar Therapeutics Inc. Common Stock currently has a market capitalization of 751.02 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Monopar Therapeutics Inc. Common Stock earnings last quarter?
Last quarter, Monopar Therapeutics Inc. Common Stock reported earnings of -0.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Monopar Therapeutics Inc. Common Stock revenue for the last quarter?
Monopar Therapeutics Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Monopar Therapeutics Inc. Common Stock net income for the last quarter?
Monopar Therapeutics Inc. Common Stock reported net income of -5.31 M for the last quarter. The previous quarter showed -3.89 M, which means net income changed by -36.48%.
How many employees does Monopar Therapeutics Inc. Common Stock have?
As of the latest available data, Monopar Therapeutics Inc. Common Stock has 22 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Monopar Therapeutics Inc. Common Stock stock?
You can buy Monopar Therapeutics Inc. Common Stock (MNPR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Monopar Therapeutics Inc. Common Stock stock?
Investing in Monopar Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MNPR chart and related analysis on metatrader.com as part of your research.